HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Medial Prefrontal Cortical Cannabinoid CB1 Receptors Mediate Morphine-Dextromethorphan Cross State-Dependent Memory: The Involvement of BDNF/cFOS Signaling Pathways.

Abstract
The present study set out to assess the possible role of the medial prefrontal cortex (mPFC) cannabinoid CB1 receptors and BDNF/cFOS signaling pathways in morphine-dextromethorphan (DXM) cross state-dependent memory (SDM) using male Wistar rats. Changes on the levels of BDNF and cFOS proteins in the PFC were examined by Western blot analysis. Present results revealed that levels of BDNF and cFOS proteins were significantly increased in the animals that were trained in the passive avoidance apparatus. Intraperitoneal injection of morphine (6 mg/kg, i.p.) after training impaired memory which was associated with decreases in the levels of both proteins. Moreover, the injection of a cannabinoid CB1 receptor agonist, ACPA, or a selective CB1 receptor antagonist, AM-251, into the mPFC prior to testing had no effect on memory retrieval by itself and also on morphine-induced memory loss. Pre-test administration of DXM (a NMDA receptors antagonist, 30 mg/kg, i.p.) impaired memory retrieval and attenuated BDNF levels. Moreover, DXM administration (pre-test) prevented morphine-induced memory loss and increased the levels of both proteins, suggesting morphine-DXM cross-SDM. Interestingly, pre-test intra-mPFC injections of ACPA inhibited cross-SDM between the drugs which was associated with an elevation of BDNF expression in the PFC. Additionally, pre-test administration of an ineffective dose of DXM (10 mg/kg, i.p.) could not reverse morphine-induced memory loss, while pre-test intra-mPFC injections of AM-251 potentiated morphine-DXM cross-SDM. Taken together, it can be concluded that mPFC through CB1cannabinoid receptors has a critical role in morphine-DXM cross-SDM which may be associated with the PFC BDNF/cFOS signaling pathway.
AuthorsZahra Ghasemzadeh, Ameneh Rezayof
JournalNeuroscience (Neuroscience) Vol. 393 Pg. 295-304 (11 21 2018) ISSN: 1873-7544 [Electronic] United States
PMID30326290 (Publication Type: Journal Article)
CopyrightCopyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Arachidonic Acids
  • Brain-Derived Neurotrophic Factor
  • Oncogene Proteins v-fos
  • Receptor, Cannabinoid, CB1
  • Dextromethorphan
  • Morphine
Topics
  • Animals
  • Arachidonic Acids (pharmacology)
  • Avoidance Learning (drug effects)
  • Brain-Derived Neurotrophic Factor (metabolism)
  • Dextromethorphan (pharmacology)
  • Male
  • Memory (drug effects)
  • Memory Disorders (metabolism)
  • Morphine (pharmacology)
  • Oncogene Proteins v-fos (metabolism)
  • Prefrontal Cortex (drug effects, metabolism)
  • Rats, Wistar
  • Receptor, Cannabinoid, CB1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: